No Evidence of Increased Side Effects from Combining mRNA Vaccines and Cosentyx
Clinical data and pharmacovigilance reports show no confirmed increased side effects when combining mRNA COVID-19 vaccines (like Pfizer-BioNTech or Moderna) with Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis. Cosentyx suppresses specific immune pathways without broadly impairing vaccine response or causing additive adverse events in studies.[1][2]
What Studies Say About Vaccine Response on Cosentyx
Real-world data from over 200 psoriasis patients on secukinumab found robust antibody responses to mRNA vaccines, comparable to healthy controls. No excess infections or hypersensitivity reactions occurred post-vaccination. Humoral immunity remained strong, with seroconversion rates above 90%.[3] A separate cohort of 150 rheumatic disease patients on biologics, including IL-17 inhibitors, reported similar safety profiles—no signals of heightened reactogenicity like fever, fatigue, or injection-site reactions.[4]
Common Side Effects of Each and Potential Overlaps
Cosentyx alone causes upper respiratory infections (14%), diarrhea (4%), and candidiasis (3%) in trials.[1] mRNA vaccines typically trigger transient arm pain, fatigue, headache, and chills in 50-80% of recipients, resolving in 1-3 days.[5] Overlaps exist in mild symptoms like fatigue or diarrhea, but no data indicates synergy or worsening. Immunosuppressed patients on biologics had vaccination side effects matching the general population.[3][4]
Risks for Immunocompromised Patients
Patients on Cosentyx have slightly higher baseline infection risks due to targeted immunosuppression, but COVID-19 breakthrough rates post-mRNA vaccination mirror non-biologic users. No excess severe events like myocarditis, thrombosis, or anaphylaxis linked to combination. Guidelines from rheumatology societies (e.g., ACR) recommend proceeding with mRNA vaccines without interruption of Cosentyx.[6] Monitor for standard post-vaccine symptoms; consult providers if active infections exist.
What If You're Concerned About Interactions?
Report any unusual symptoms to VAERS or your doctor. No drug interaction warnings appear in Cosentyx labeling or vaccine inserts for this pairing. Timing Cosentyx doses away from vaccination (e.g., 1-2 weeks) is sometimes advised anecdotally but lacks trial support.[2][6]
Sources
[1] Cosentyx Prescribing Information (Novartis)
[2] Drugs.com Drug Interactions Checker
[3] JAMA Dermatology: Antibody Response to COVID-19 Vaccines in Psoriasis Patients on Biologics (2021)
[4] Annals of Rheumatic Diseases: Safety of COVID-19 Vaccination in IBD and Rheumatic Patients (2022)
[5] CDC Vaccine Safety Data
[6] American College of Rheumatology COVID-19 Vaccine Guidance (2023)